Kontour Medical Technology Stock Retained Earnings
| 688314 Stock | 29.78 0.16 0.53% |
Kontour Medical Technology fundamentals help investors to digest information that contributes to Kontour (Xian)'s financial success or failures. It also enables traders to predict the movement of Kontour Stock. The fundamental analysis module provides a way to measure Kontour (Xian)'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kontour (Xian) stock.
| Last Reported | Projected for Next Year | ||
| Retained Earnings | 189.6 M | 103.6 M |
Kontour | Retained Earnings |
Kontour Medical Technology Company Retained Earnings Analysis
Kontour (Xian)'s Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Kontour (Xian) Retained Earnings | 164.9 M |
Most of Kontour (Xian)'s fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kontour Medical Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, Kontour Medical Technology has a Retained Earnings of 164.9 M. This is 82.29% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The retained earnings for all China stocks is 98.23% higher than that of the company.
Kontour Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kontour (Xian)'s direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kontour (Xian) could also be used in its relative valuation, which is a method of valuing Kontour (Xian) by comparing valuation metrics of similar companies.Kontour Medical is currently under evaluation in retained earnings category among its peers.
Kontour Fundamentals
| Current Valuation | 2.08 B | ||||
| Price To Book | 3.79 X | ||||
| Price To Sales | 7.85 X | ||||
| Revenue | 275.03 M | ||||
| EBITDA | 106.76 M | ||||
| Net Income | 75.51 M | ||||
| Total Debt | 37.97 M | ||||
| Cash Flow From Operations | 85.22 M | ||||
| Total Asset | 675.79 M | ||||
| Retained Earnings | 164.9 M | ||||
| Working Capital | 346.95 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 675.79 M |
About Kontour (Xian) Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kontour Medical Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kontour (Xian) using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kontour Medical Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in Kontour Stock
Kontour (Xian) financial ratios help investors to determine whether Kontour Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kontour with respect to the benefits of owning Kontour (Xian) security.